172 related articles for article (PubMed ID: 29489658)
21. Headache in late pregnancy: a symptom for Vogt-Koyanagi-Harada disease.
Matsubara S; Kuwata T; Ohkawara Y; Makino S
Arch Gynecol Obstet; 2011 Jun; 283(6):1423-5. PubMed ID: 21046128
[TBL] [Abstract][Full Text] [Related]
22. Headache as a first manifestation of Vogt-Koyanagi-Harada disease.
Kosma KK; Kararizou E; Markou I; Eforakopoulou E; Kararizos G; Mitsonis C; Gkiatas K
Med Princ Pract; 2008; 17(3):253-4. PubMed ID: 18408397
[TBL] [Abstract][Full Text] [Related]
23. Early phase Vogt-Koyanagi-Harada Disease in Nepalese Elderly woman: A case report.
Bahadur BT; Gurung S; Singh S; Aryal M
Nepal J Ophthalmol; 2020 Jan; 12(23):146-152. PubMed ID: 32799253
[TBL] [Abstract][Full Text] [Related]
24. Unusual Case of Vogt-Koyanagi-Harada Syndrome Presenting as Non-specific Headache.
A V P; Kumar J S A; K N N; Rao S; Shetty S
J Clin Diagn Res; 2014 Apr; 8(4):VD06-VD07. PubMed ID: 24959501
[TBL] [Abstract][Full Text] [Related]
25. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
Manethova K; Ernest J; Hrevus M
Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Takayama K; Obata H; Takeuchi M
Ocul Immunol Inflamm; 2020 Apr; 28(3):509-512. PubMed ID: 31268769
[No Abstract] [Full Text] [Related]
27. Management of a rare presentation of Vogt-Koyanagi-Harada disease in human immunodeficiency virus/acquired immunodeficiency disease syndrome patient.
Priya D; Sudharshan S; Biswas J
Indian J Ophthalmol; 2017 May; 65(5):413-416. PubMed ID: 28574002
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and immunohistochemistry correlation in a case of Vogt-Koyanagi-Harada disease.
Das D; Boddepalli A; Biswas J
Indian J Ophthalmol; 2019 Jul; 67(7):1217-1219. PubMed ID: 31238472
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report.
Niidome S; Usui Y; Tsubota K; Sugawara R; Goto H
Ocul Immunol Inflamm; 2023 Aug; 31(6):1305-1309. PubMed ID: 37084286
[TBL] [Abstract][Full Text] [Related]
30. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N
Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415
[TBL] [Abstract][Full Text] [Related]
31. Acute retinal necrosis (ARN) following chickenpox in a patient of Vogt-Koyanagi-Harada (VKH) syndrome using immunosuppressants.
Gupta R; Tyagi M; Balakrishnan D; Rani PK
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567136
[TBL] [Abstract][Full Text] [Related]
32. Vogt-Koyanagi-Harada syndrome in a Greenlandic Inuit.
Ostergaard J; Goldschmidt E; Andersen N
Acta Ophthalmol; 2008 Aug; 86(5):576-8. PubMed ID: 18039349
[TBL] [Abstract][Full Text] [Related]
33. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
[TBL] [Abstract][Full Text] [Related]
34. Teaching NeuroImages: A case of Vogt-Koyanagi-Harada disease with bilateral retinal detachment.
Al Banna M; Reeder S; Ghannam M; Robertson J; Stutz A
Neurology; 2019 Jul; 93(4):e421. PubMed ID: 31332094
[No Abstract] [Full Text] [Related]
35. Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
Koong LR; Chee WK; Toh ZH; Ng XL; Agrawal R; Ho SL
Ocul Immunol Inflamm; 2021 Aug; 29(6):1212-1215. PubMed ID: 34505819
[TBL] [Abstract][Full Text] [Related]
36. Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
Joo CW; Kim YK; Park SP
Ocul Immunol Inflamm; 2022 Jul; 30(5):1250-1254. PubMed ID: 35404752
[TBL] [Abstract][Full Text] [Related]
37. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
Chew SK; Levy J; Rogers S; Lim LL
Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
[TBL] [Abstract][Full Text] [Related]
38. [Vogt-Koyanagi-Harada syndrome in children - a case report].
Bušányová B; Tomčíková D; Gerinec A
Cesk Slov Oftalmol; 2013 Jun; 69(2):81-6. PubMed ID: 23964873
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
Park HS; Nam KY; Kim JY
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
[TBL] [Abstract][Full Text] [Related]
40. Vogt-Koyanagi-Harada syndrome in children: report of a case and review of the literature.
Berker N; Ozdamar Y; Soykan E; Ozdal P; Ozkan SS
Ocul Immunol Inflamm; 2007; 15(4):351-7. PubMed ID: 17763135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
